Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
InvestorsHub55d agoneutral
Novo Nordisk Adopts Novo as Everyday Operating Name and Introduces New Cultural FrameworkThe Wall Street Journal57d agoneutral
Heart Disease, a Historic Strength for Big Pharma, Becomes a WeaknessYahoo Finance61d agoneutral
Why the CEO of Wegovy maker Novo Nordisk isn't yet sold on the peptide crazeYahoo Finance61d agoneutral
Why CEO of Wegovy maker Novo Nordisk isn't sold yet on the peptide crazeSimply Wall St.65d agoneutral
Novo Nordisk (CPSE:NOVO B) Stock Looks Below Fair Value But Faces Earnings DoubtsGuruFocus.com68d agoneutral
Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in GermanyInvestor's Business Daily79d agoneutral
Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The Clear WinnerThe Wall Street Journal81d agoneutral
Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss PillsInvestor's Business Daily81d agoneutral
Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills MarketInvestor's Business Daily82d agoneutral
Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss PillsInvesting.com82d agoneutral
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"MT Newswires87d agoneutral
European Stocks Close Mixed in Thursday Trading; UK GDP Growth Slows in Q2